Frontlight ResearchEarly access
Acute myeloid leukaemia trials in United States
334 trials · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 1Not yet taking people in United StatesStudy of Monzosertib In Patients With R/R AML Or High-Risk Myelodysplastic Syndrome
- Where
- Houston
- Age
- 18 years and over
- People
- 42
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07780565 - Phase 1Taking peopleSafety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
- Where
- Allentown, Atlanta, Augusta, Boston, Buffalo, Burlington, Charlotte, Charlottesville, Chicago, Cleveland, Dallas, Denver, Detroit, Gilbert, Greenville, Hackensack, Houston, Iowa City, Kansas City, Lake Success, Los Angeles, Maywood, Milwaukee, Nashville, New Haven, New York, Oklahoma City, Omaha, Orange, Rochester, San Francisco, Seattle, Springfield, St Louis, Stony Brook
- Age
- 18 years and over
- People
- 171 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT06001788 · EU 2023-510288-37-00 - No phaseTaking peopleAcute Myeloid Leukemia and Markers of Leukemia Stem Cells (CLL1 and CD45RA)
- Where
- Stony Brook
- Age
- 18 years and over
- People
- 20
- Run by
- Suhu Liu
See details and how to joinNCT06297551 - Phase 1Taking peopleEltanexor and Venetoclax in Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
- Where
- Memphis, Nashville
- Age
- 18 years and over
- People
- 60
- Run by
- Vanderbilt-Ingram Cancer Center
See details and how to joinNCT06399640 - No phaseTaking peopleEvaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia
- Where
- Seattle
- Age
- 18 years and over
- People
- 50
- Run by
- University of Washington
See details and how to joinNCT06710418 - Phase 1Taking peopleICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
- Where
- Chapel Hill, Milwaukee, New Haven, New York, Orange, Tampa
- Age
- 18 years and over
- People
- 266 worldwide
- Run by
- Beijing InnoCare Pharma Tech Co., Ltd.
See details and how to joinNCT06656494 - Phase 1Taking peopleThiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
- Where
- Pittsburgh
- Age
- 18 years and over
- People
- 48
- Run by
- Sawa Ito, MD
See details and how to joinNCT07565220 - Early phase 1Taking peopleA Pilot Study of Soursop Tea in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Multiple Myeloma (MM)
- Where
- Camden
- Age
- 18 years and over
- People
- 20
- Run by
- Roger Strair
See details and how to joinNCT07771803 - Phase 1Taking peopleTACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
- Where
- Palo Alto
- Age
- 18 years to 80 years
- People
- 50
- Run by
- Stanford University
See details and how to joinNCT07302776 - Phase 1Taking peopleMulti-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies
- Where
- Baltimore, Washington D.C.
- Age
- 6 months to 80 years
- People
- 50
- Run by
- Catherine Bollard
See details and how to joinNCT02203903 - Phase 2Taking peopleFractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia
- Where
- Seattle
- Age
- 18 years and over
- People
- 36
- Run by
- University of Washington
See details and how to joinNCT03737955 - No phaseTaking peopleeHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation
- Where
- Miami
- Age
- 18 years and over
- People
- 165
- Run by
- University of Miami
See details and how to joinNCT07469592 - Phase 2/3Taking peopleVenetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDS
- Where
- Houston
- Age
- 18 years to 70 years
- People
- 324
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT04708054 - Phase 2Taking peopleInterferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation
- Where
- Pittsburgh, Seattle, St Louis
- Age
- 18 years and over
- People
- 57
- Run by
- Sawa Ito, MD
See details and how to joinNCT06529731 - Phase 4Taking peopleOlutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
- Where
- New York, Orange
- Age
- 18 years and over
- People
- 16
- Run by
- Rigel Pharmaceuticals
See details and how to joinNCT07486713 - Phase 1Taking peoplePhase I Study of HC-7366 for Acute Myeloid Leukemia
- Where
- Houston
- Age
- 18 years and over
- People
- 18
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT06285890 - No phaseTaking peopleTempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer
- Where
- Chicago
- People
- 1,000
- Run by
- Tempus AI
See details and how to joinNCT07756034 - Phase 1/2Taking peoplePhase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
- Where
- Houston
- Age
- 12 years to 80 years
- People
- 80
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT05092451 - Phase 1Taking peopleFH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Where
- Seattle
- Age
- Up to 6 years
- People
- 12
- Run by
- Fred Hutchinson Cancer Center
See details and how to joinNCT06609928 - Phase 2/3Taking peopleL-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
- Where
- Augusta, Birmingham, Cleveland, Miami, Morristown, Omaha, Philadelphia, Providence
- Age
- 18 years to 80 years
- People
- 312 worldwide
- Run by
- Moleculin Biotech, Inc.
See details and how to joinNCT06788756 · EU 2024-518359-47-00 - Phase 2Not yet taking people in United StatesGeriatric Assessment-Guided Treatment Selection in Older Adults With Acute Myeloid Leukemia
- Where
- Rochester
- Age
- 60 years and over
- People
- 120
- Run by
- University of Rochester
See details and how to joinNCT07735208 - Phase 2Enrolling by invitationA Study for Participants Who Participated in Prior Clinical Studies of ASTX727 (Standard Dose)
- Where
- Baltimore, Buffalo, Canton, Charleston, Chicago, Dallas, Fountain Valley, Grand Rapids, Hackensack, Houston, Kennewick, Nashville, Plantation, Portland, Rochester, San Antonio, Seattle
- Age
- 18 years and over
- People
- 332 worldwide
- Run by
- Taiho Oncology, Inc.
See details and how to joinNCT04093570 · EU 2024-516293-29-01 - No phaseNot yet taking people in United StatesPRAISE-IR Versus CIBMTR Controls
- Where
- New York
- Age
- 1 year to 66 years
- People
- 51
- Run by
- Miltenyi Biomedicine GmbH
See details and how to joinNCT07717164 - No phaseTaking peopleToxicity Genetic Determinants and Response to Azacitidine and Venetoclax in AML
- Where
- Charlotte, Winston-Salem
- Age
- 18 years and over
- People
- 50
- Run by
- Wake Forest University Health Sciences
See details and how to joinNCT06580106 - Phase 2Taking peopleMotixafortide for MRD Sensitization in AML
- Where
- St Louis
- Age
- 18 years and over
- People
- 10
- Run by
- Washington University School of Medicine
See details and how to joinNCT07392970